The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management

References

• Hugh R, Ryschenkow E. Pseudomonas maltophilia, an Alcaligenes-like species. J Gen Microbiol 1961; 26: 123–132
   PubMedGoogle Scholar
• Swings, J, DeVos, M, Van der Mooter, M, et al. Transfer of Pseudomonas mallophilia Hugh 1981 to the genus Xanthomonas as Xanthomonas maltophilia (Hugh (1981) comb. nov. Internat J Syst Bacteriol 1983; 33: 409–413
   Google Scholar
• van Zyl E, Steyn P. Reinterpretation of the taxonomic position of Xanthomonas maltophilia and taxonomic criteria in this genus. Int J Syst Bacteriol 1992; 42: 193–198
   PubMedGoogle Scholar
• Blazevic D. Current taxonomy and identification of non-fermatative Gram negative bacilli. Human Path 1976; 7: 265–275
   PubMed Web of Science ®Google Scholar
• Khardori, N, Elting, L, Wong, E, et al. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 1990; 12: 997–1003
   PubMedGoogle Scholar
• Muder, R, Yu, V, Dummer, S, et al. Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. Arch Intern Med 1987; 147: 1672–1674
   PubMed Web of Science ®Google Scholar
• Marshall, W, Keating, M, Anhalt, J, et al. Xanthomonas maltophilia: An emerging nosocomial pathogen. Mayo Clin Proc 1989; 64: 1097–1104
   PubMed Web of Science ®Google Scholar
• Elting, L, Khardori, N, Bodey, G, et al. Nosocomial infection caused by Xanthomonas maltophilia: A case-control study of predisposing factors. Infect Control Hosp Epidemiol 1990; 11: 134–138
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow anaerobically. NCCLS Document M7-A2. NCCLS, Villanova, Pa 1990
   Google Scholar
• National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourth Information Supplement. NCCLS Document M100-S4. NCCLS, Villanova, Pa 1992
   Google Scholar
• Moody M, Young V. In vitro susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother 1975; 7: 836–839
   PubMed Web of Science ®Google Scholar
• Metchock B, Thornsberry C. Susceptibility of Xanthomonas (Pseudomonas) maltophilia to antimicrobial agents: Methodological problems. Antimicrobic Newsletter 1989; 6: 35–40
   Google Scholar
• Hohl P, Frei R, Aubry P. In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Diagn Microbiol Infect Dis 1991; 14: 447–450
   PubMed Web of Science ®Google Scholar
• Khardori, N, Reuben, A, Rosenbaum, B, et al. In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents. Antimicrob Agents Chemother 1990; 34: 1609–1610
   PubMed Web of Science ®Google Scholar
• Saino, Y, Kobayashi, F, Inoue, M, et al. Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia. Antimicrob Agents Chemother 1982; 22: 564–570
   PubMed Web of Science ®Google Scholar
• Saino Y, Inoue M, Mitsuhashi S. Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN 12873. Antimicrob Agents Chemother 1984; 25: 362–365
   PubMed Web of Science ®Google Scholar
• Akova M, Bonfiglio G, Livermore D. Susceptibility to β-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 β-lactamases. J Med Microbiol 1991; 35: 208–213
   PubMed Web of Science ®Google Scholar
• Mett, H, Rosta, S, Schacher, B, et al. Outer membrane permeability and β-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants. Rev Infect Dis 1988; 10: 765–769
   PubMedGoogle Scholar
• Cullmann W. Antibiotic susceptibility and outer membrane proteins of clinical Xanthomonas maltophilia isolates. Chemotherapy 1991; 37: 246–250
   PubMed Web of Science ®Google Scholar
• Traub W, Spohr M. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia. Chemotherapy 1987; 33: 340–346
   PubMed Web of Science ®Google Scholar
• Neu H, Saha G, Chin N. Resistance of Xanthomonas maltophilia to antibiotics and the effect of β-lactamase inhibitors. Diagn Microbiol Infect Dis 1989; 12: 283–285
   PubMed Web of Science ®Google Scholar
• Garcia-Rodriguez, J, Garcia Sanchez, J, et al. Antibiotic susceptibility profile of Xanthomonas maltophilia. Diagn Microbiol Infect Dis 1991; 14: 239–243
   PubMed Web of Science ®Google Scholar
• Bicknell, R, Emanuel, E, Gagnon, J, et al. The production and molecular properties of the zine β-lactamase of Pseudomonas maltophilia IID 1275. Biochem J 1985; 229: 791–797
   PubMed Web of Science ®Google Scholar
• Yang Y, Wu P, Livermore D. Biochemical characterization of a β-lactamase that hydrolyses penems and carbapenems from two Serratia Marcescens isolates. Antimicrob Agents Chemother 1990; 34: 755–758
   PubMed Web of Science ®Google Scholar
• Cuchural G, Malamy M, Tally F. β-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother 1986; 30: 645–648
   PubMed Web of Science ®Google Scholar
• Trias J, Nikaido H. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990; 34: 52–57
   PubMed Web of Science ®Google Scholar
• Calandra, G, Brown, K, Grad, C, et al. Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin. Am J Med 1985; 78(suppl 6A)73–78
   PubMed Web of Science ®Google Scholar
• Chow A, Wong J, Bartlett K. Synergistic interactions of ciprofloxacin and extended spectrum β-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia. Antimicrob Agents Chemother 1988; 32: 782–784
   PubMed Web of Science ®Google Scholar
• Wheat P, Winstanley T, Spencer R. Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia. J Clin Pathol 1985; 38: 1055–1058
   PubMed Web of Science ®Google Scholar